Browse Psychiatry and Behavioral Sciences

Philippe Mourrain

Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator)

BioExpertise: Neurobiology, Sleep sciences, Molecular Genetics, Developmental Biology, Gene Silencing/Epigenetics

Methodology: Synapse Imaging (Two photon microscopy, Array Tomography), Calcium Imaging (Light Sheet Microscopy/SPIM, Light Field Microscopy), Optogenetics, CLARITY, Tol2 transgenesis, TALENs, CRISPR/Cas9, Video tracking and behavior computation.

Anna E. Muelling

Emeritus Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences

Pavithra Mukunda

Clinical Rsch Mgr, Psych/Public Mental Health & Population Sciences

Current Role at StanfordClinical Research Manager

Elvis Raymond Mukwikwi, MD

Fellow in Psychiatry and Behavioral Sciences

BioDr. Elvis Raymond Mukwikwi is a geriatric psychiatry fellow at Stanford University. He completed his medical training at the University of Montreal, followed by a specialization in psychiatry at McGill University. In addition to his clinical training, Dr. Mukwikwi is actively involved in neuropsychiatry research and has published work focusing on frontotemporal dementia. Beyond his clinical work, he is dedicated to patient advocacy.

Martin Stefan Mumenthaler

Adjunct Professor, Psych/Public Mental Health & Population Sciences

BioMartin Mumenthaler has a PharmD and a PhD in psychopharmacology from the University of Bern, Switzerland. He holds an appointment as Adjunct Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine where he has been conducting research programs in addiction medicine and psychopharmacology, and teaching and mentoring medical students and residents on a voluntary basis.
Dr. Mumenthaler has also been working in various full-time positions in the pharmaceutical industry as Director in Clinical Development as well as in Medical Affairs, and as a consultant for early-stage pharma- and biotech companies providing advice on designing and conducting clinical trials, and analyzing and interpreting study results, mainly in the field of addiction medicine and pain.
His academic research has focused on the effects of psychoactive drugs on human performance, Aerospace Medicine, Alzheimer’s disease, and addiction medicine, and in these areas he has presented his results internationally and published over twenty-five peer-reviewed scientific articles. He has also served as a reviewer for various scientific journals, and is a member of the Research Society on Alcoholism, and an Associate Fellow of the Aerospace Medical Association.